IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS
Other Strategic 87 108 110 115 121 127 134 134
Mature Products 97 88 85 85 85 85 85 85
Respiratory 959 1,089 1,104 1,163 1,208 1,243 1,280 1,293
Zelnorm 88 13 13 13 13 13 13 13
Visudyne 179 129 106 90 86 81 77 74
Lucentis 393 904 1,006 1,106 1,162 1,220 1,281 1,345
Elidel 176 157 145 137 131 124 118 112
Enablex 179 210 224 242 254 267 280 288
Other Strategic 426 207 213 221 228 235 242 242
Lamisil 595 266 202 162 130 104 84 79
Mature Products 116 134 130 130 130 130 130 130
Ophthalmics/
Dermatology/GI 2,152 2,020 2,037 2,101 2,132 2,173 2,223 2,282
Galvus — 50 80 130 250 340 430 473
Prexige 91 26 26 26 26 26 26 26
Other Strategic 11 43 42 42 42 42 42 42
Miacalcic 281 253 232 221 210 199 189 180
Voltaren 747 821 755 717 681 647 615 584
Mature Products 411 211 199 193 187 181 176 167
Arthritis/Bone/Pain 1,571 1,639 1,673 1,872 2,211 2,341 2,384 1,472
Neoral/Sandimmun 944 960 869 826 784 745 708 672
Sebivo (telbivudine) 88 230 346 451 509 543 572 600
Famvir 236 100 94 92 89 86 84 81
Other Strategic 74 85 86 90 95 100 105 107
Mature Products 300 233 214 204 193 184 175 166
Infection/
Transplantation/
Immunology 1,642 1,608 1,609 1,662 1,670 1,657 1,642 1,626
PIPELINE PRODUCTS — — 142 551 1,355 2,444 3,415 4,105
TOTAL PHARMA 24,025 26,421 27,582 29,606 31,077 30,566 28,101 25,939
Vaccines and Diagnostics 1,452 1,720 1,837 2,248 2,908 3,818 4,754 5,125
Sandoz 7,169 7,655 7,820 8,308 8,807 9,247 9,617 9,906
Consumer Health
(ongoing) 5,426 5,886 6,152 6,521 6,782 7,053 7,335 7,555
TOTAL SALES
(reported) 39,800 41,683 43,390 53,528 56,938 58,613 58,345 57,643
© 2009 IMS Health In cor po rated or its af fil i ates Page 117